We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Breakthrough in Nanosized Contrast Agents to Enhance Magnetic Resonance Imaging

By MedImaging International staff writers
Posted on 06 Dec 2023
Print article
Image: Self-folding mechanism leads to enhanced contrast in MRI scans (Photo courtesy of Tokyo Tech)
Image: Self-folding mechanism leads to enhanced contrast in MRI scans (Photo courtesy of Tokyo Tech)

Magnetic resonance imaging (MRI) plays a vital role in cancer diagnosis by capturing detailed images of soft tissues. For enhanced tumor visibility in MRI scans, doctors often administer contrast agents to patients. These agents impact the response of surrounding hydrogen ions to MRI's radiofrequency pulses. The aim of using contrast agents is to have them specifically accumulate in tumors, thereby heightening their visibility in the scans. However, traditional gadolinium (Gd)-chelate contrast agents have nearly reached their performance peak. One of the main challenges is achieving an optimal dose in the distribution of Gd-chelate in tumors, healthy tissue, and blood without excessive Gd doses.

In response, a collaborative study by a research team that included scientists from Tokyo Institute of Technology (Tokyo, Japan) has led to the development of a groundbreaking nano-contrast agent (NCA) using an innovative molecular design. This NCA utilizes Gd as the contrast agent within a "self-folding macromolecular drug carrier (SMDC)." The team integrated clinically approved Gd-containing chelates into a polymer chain comprising poly(ethylene glycol) methyl ether acrylate (PEGA) and benzyl acrylate (BZA). This polymer, featuring both hydrophilic and hydrophobic sections, spontaneously forms a small, capsule-like structure in water, positioning the hydrophobic segments internally and the hydrophilic ones externally.

This methodology allowed for the production of SMDC-Gds molecules under 10 nanometers in size. Experiments on mice with colon cancer demonstrated that these NCAs accumulated more effectively in tumors and were rapidly cleared from the bloodstream, thus enhancing MRI capabilities without toxic side effects. Furthermore, the team uncovered an additional benefit of SMDC-Gds over existing Gd-chelates. The optimal performance of Gd ions is achieved when their movement is restricted, ensuring a consistent and prolonged impact on neighboring hydrogen ions. The SMDC's core/shell structure creates a densely packed molecular environment that limits the rotation and internal motions of Gd ions, thereby resulting in a stronger contrast in MRI images. This will enable the use of alternative elements with safer profiles in patients as well as the environment in the future.

Beyond MRI applications, SMDC-Gds show promise in neutron capture therapy (NCT), an emerging targeted radiotherapy method. In NCT, Gds capture neutrons and emit high-energy radiation, destroying cancer cells in proximity. Experiments showed that NCT with repeated SMDC-Gd injections significantly reduced tumor growth, which can be attributed to the selective accumulation and deep penetration of SMDC-Gds in tumor tissues. The research highlights the potential of SMDCs not just for improved MRI diagnostics, but also as effective cancer treatment modalities and other medical applications.

"This study presents further possibilities for exploiting drug delivery using various therapeutic cargos, and we are currently investigating the development of such SMDC systems," said Associate Professor Yutaka Miura of Tokyo Tech who led the research team.

Related Links:
Tokyo Institute of Technology

Gold Member
Solid State Kv/Dose Multi-Sensor
Ultrasound Doppler System
Doppler BT-200
Portable X-Ray Unit
Digital Radiography Acquisition Software
VXvue with PureImpact

Print article



view channel
Image: LumiGuide enables doctors to navigate through blood vessels using light instead of X-ray (Photo courtesy of Philips)

3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery

In vascular surgery, doctors frequently employ endovascular surgery techniques using tools such as guidewires and catheters, often accessing through arteries like the femoral artery. This method is known... Read more


view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.